{"id":51193,"date":"2025-01-29T16:55:14","date_gmt":"2025-01-29T15:55:14","guid":{"rendered":"https:\/\/editing.capitalmind.com\/?post_type=deals&p=51193"},"modified":"2025-01-29T17:28:52","modified_gmt":"2025-01-29T16:28:52","slug":"cession-de-baccinex-a-adragos-pharma","status":"publish","type":"deals","link":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/","title":{"rendered":"Cession de Baccinex \u00e0 Adragos Pharma"},"content":{"rendered":"\n

Capitalmind Investec a conseill\u00e9 Baccinex lors de sa cession \u00e0 Adragos Pharma<\/strong><\/p>\n\n\n\n

A propos du deal<\/h2>\n\n\n\n

Capitalmind Investec a \u00e9t\u00e9 le conseil financier exclusif de Baccinex lors de sa cession \u00e0 Adragos Pharma (Adragos).<\/p>\n\n\n\n

Entreprise familiale fond\u00e9e \u00e0 Courroux en 1999, Baccinex SA est un laboratoire pharmaceutique sous-traitant sp\u00e9cialis\u00e9 dans le d\u00e9veloppement et dans la fabrication de produits (bio)pharmaceutiques injectables, liquides ou lyophilis\u00e9s. Reconnue pour sa flexibilit\u00e9 et sa r\u00e9activit\u00e9 dans un environnement extr\u00eamement exigeant, elle s\u2019est impos\u00e9e dans la fabrication de produits \u00e0 tr\u00e8s haute valeur ajout\u00e9e en collaboration avec des partenaires suisses et internationaux. Cette entreprise jurassienne est un maillon primordial dans le d\u00e9veloppement des traitements d\u2019avant-garde comme par exemple cinq m\u00e9dicaments pour lutter contre le Covid-19. Baccinex SA emploie quelque 120 collaborateurs.<\/p>\n\n\n\n

Adragos est une organisation de d\u00e9veloppement et de Fabrication Contractuelle (CDMO) op\u00e9rant \u00e0 l’\u00e9chelle mondiale et dont le si\u00e8ge social est en Allemagne. Avec un r\u00e9seau de six sites de production en Europe et au Japon, Adragos offre des services pharmaceutiques complets, soutenant ses clients depuis le d\u00e9veloppement jusqu’\u00e0 la production commerciale.<\/p>\n\n\n\n

Avec l’acquisition de Baccinex, Adragos est d\u00e9sormais en mesure d’offrir \u00e0 ses clients des services de pointe dans le domaine de la fabrication aseptique de produits pharmaceutiques st\u00e9riles lyophilis\u00e9s ou liquides en Suisse. Il offre son expertise aux entreprises (bio)pharmaceutiques de toute taille, en tant que sous-traitant pharmaceutique (CDMO) pour la production de lots cliniques et commerciaux \u00e0 petite \u00e9chelle dans son site de production suisse certifi\u00e9 EU-GMP.\u00a0La transaction marque une \u00e9tape cruciale dans l’expansion de son r\u00e9seau mondial. L’acquisition de Baccinex s’inscrit parfaitement dans la strat\u00e9gie d’Adragos visant \u00e0 construire un r\u00e9seau de production de classe mondiale qui fournit des solutions sur mesure pour r\u00e9pondre aux besoins \u00e9volutifs de ses clients.<\/p>\n\n\n\n

Dr Ursula Bausch continuera \u00e0 diriger Baccinex en tant que PDG, assurant la continuit\u00e9 des op\u00e9rations et tirant parti de sa grande expertise en mati\u00e8re de fabrication st\u00e9rile. Elle restera \u00e9galement actionnaire minoritaire de la soci\u00e9t\u00e9, ce qui t\u00e9moigne de son engagement ferme en faveur de la poursuite de son succ\u00e8s dans le cadre d’Adragos.<\/p>\n\n\n\n

Notre r\u00f4le<\/h2>\n\n\n\n

L’\u00e9quipe Capitalmind Investec a conseill\u00e9 Baccinex tout au long du processus de M&A jusqu’\u00e0 la finalisation de la transaction :<\/p>\n\n\n\n

  • Pr\u00e9paration du business plan et du mat\u00e9riel de marketing<\/li><\/ul><\/p>\n\n\n\n

    • Identification d’acheteurs potentiels (strat\u00e9giques et financiers)<\/li><\/ul><\/p>\n\n\n\n

      • Approche du march\u00e9 et mise en place d’un processus de vente comp\u00e9titif<\/li><\/ul><\/p>\n\n\n\n

        • Pr\u00e9paration et soutien de l’audit pr\u00e9alable (due diligence)<\/li><\/ul><\/p>\n\n\n\n

          • Aide \u00e0 la n\u00e9gociation de la documentation juridique<\/li><\/ul><\/p>\n\n\n\n

            • Coordination de toutes les parties concern\u00e9es, y compris les conseillers juridiques et fiscaux<\/li><\/ul><\/p>\n\n\n\n

              \u201cCapitalmind Investec a g\u00e9r\u00e9 l’ensemble du processus de transaction de mani\u00e8re tr\u00e8s professionnelle et a fait preuve d’une grande disponibilit\u00e9 et d’une grande r\u00e9activit\u00e9. Gr\u00e2ce \u00e0 son r\u00e9seau international et \u00e0 sa connaissance approfondie du secteur des services pharmaceutiques, nous avons pu \u00e9valuer plusieurs options de partenariat et r\u00e9aliser une transaction solide avec un CDMO de premier plan \u00e0 l’\u00e9chelle internationale, ce qui a permis \u00e0 Baccinex de b\u00e9n\u00e9ficier de synergies strat\u00e9giques \u00e9troites et d’une croissance continue.\u00a0\u00bb<\/em><\/p>\n\n\n\n

              Dr. Ursula Bausch, fondatrice de Baccinex<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

              Capitalmind Investec a conseill\u00e9 Baccinex lors de sa cession \u00e0 Adragos Pharma A propos du deal Capitalmind Investec a \u00e9t\u00e9…<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[3768],"dealtype":[3706],"clienttype":[3729],"class_list":["post-51193","deals","type-deals","status-publish","hentry","sector-healthcare-fr","dealtype-cession-fr","clienttype-entrepreneurs-fr"],"acf":[],"yoast_head":"\nCession de Baccinex \u00e0 Adragos Pharma | Investec Business Advisory<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cession de Baccinex \u00e0 Adragos Pharma\" \/>\n<meta property=\"og:description\" content=\"Capitalmind Investec a conseill\u00e9 Baccinex lors de sa cession \u00e0 Adragos Pharma A propos du deal Capitalmind Investec a \u00e9t\u00e9...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-29T16:28:52+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/\",\"name\":\"Cession de Baccinex \u00e0 Adragos Pharma | Investec Business Advisory\",\"isPartOf\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#website\"},\"datePublished\":\"2025-01-29T15:55:14+00:00\",\"dateModified\":\"2025-01-29T16:28:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/working.capitalmind.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cession de Baccinex \u00e0 Adragos Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#website\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/working.capitalmind.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory\",\"https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cession de Baccinex \u00e0 Adragos Pharma | Investec Business Advisory","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Cession de Baccinex \u00e0 Adragos Pharma","og_description":"Capitalmind Investec a conseill\u00e9 Baccinex lors de sa cession \u00e0 Adragos Pharma A propos du deal Capitalmind Investec a \u00e9t\u00e9...","og_url":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/","og_site_name":"Investec Business Advisory","article_modified_time":"2025-01-29T16:28:52+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/","url":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/","name":"Cession de Baccinex \u00e0 Adragos Pharma | Investec Business Advisory","isPartOf":{"@id":"https:\/\/working.capitalmind.com\/fr\/#website"},"datePublished":"2025-01-29T15:55:14+00:00","dateModified":"2025-01-29T16:28:52+00:00","breadcrumb":{"@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/working.capitalmind.com\/fr\/deals\/cession-de-baccinex-a-adragos-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/working.capitalmind.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Cession de Baccinex \u00e0 Adragos Pharma"}]},{"@type":"WebSite","@id":"https:\/\/working.capitalmind.com\/fr\/#website","url":"https:\/\/working.capitalmind.com\/fr\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/working.capitalmind.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/working.capitalmind.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/working.capitalmind.com\/fr\/#organization","name":"Capitalmind Investec","url":"https:\/\/working.capitalmind.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals\/51193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/media?parent=51193"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/dt?post=51193"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/sector?post=51193"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/dealtype?post=51193"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/clienttype?post=51193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}